VIZZ (aceclidine ophthalmic solution 1.44%), the flagship FDA-approved presbyopia eye drop manufactured by LENZ Therapeutics, is typically priced around $79 per month for a standard supply of 25 single-dose vials when ordered through direct-to-consumer partner pharmacy channels. Cash prices at traditional retail pharmacies generally hover near $81, though overall patient costs vary depending on commercial health insurance coverage, prior authorization terms, and manufacturer savings card programs.